Abstract
Background and aim: Hepatocellular carcinoma (HCC) is asymptomatic at an early stage which delays its timely diagnosis and treatment. Circulating tumor cells (CTCs), derived from a primary or secondary tumor, may help in the management of HCC. Here, we evaluate and characterize CTCs in HCC and liver cirrhosis (LC) patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have